MASI Masimo Corporation Stock Quote

MASI [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	56.10	EPS (ttm)	3.94	Insider Own	1.00%	Shs Outstand	55.20M	Perf Week	-4.78%
Market Cap	12.21B	Forward P/E	50.95	EPS next Y	4.34	Insider Trans	-36.41%	Shs Float	50.79M	Perf Month	-5.62%
Income	229.20M	PEG	4.71	EPS next Q	0.91	Inst Own	84.40%	Short Float	1.53%	Perf Quarter	-14.46%
Sales	1.17B	P/S	10.41	EPS this Y	20.50%	Inst Trans	-0.09%	Short Ratio	2.32	Perf Half Y	-1.79%
Book/sh	24.06	P/B	9.20	EPS next Y	14.89%	ROA	13.80%	Target Price	295.67	Perf Year	-5.41%
Cash/sh	-	P/C	-	EPS next 5Y	11.90%	ROE	16.70%	52W Range	203.81 - 284.86	Perf YTD	-17.53%
Dividend	-	P/FCF	66.56	EPS past 5Y	21.70%	ROI	16.50%	52W High	-22.30%	Beta	0.74
Dividend %	-	Quick Ratio	3.90	Sales past 5Y	12.70%	Gross Margin	64.30%	52W Low	8.60%	ATR	6.10
Employees	1600	Current Ratio	5.00	Sales Q/Q	10.90%	Oper. Margin	21.50%	RSI (14)	33.59	Volatility	2.66% 2.51%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-17.60%	Profit Margin	19.50%	Rel Volume	1.36	Prev Close	223.48
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Apr 26 AMC	Payout	0.00%	Avg Volume	334.99K	Price	221.33
Recom	2.00	SMA20	-6.93%	SMA50	-5.99%	SMA200	-8.39%	Volume	453,918	Change	-0.96%

Sep-02-20

Initiated

Robert W. Baird

Outperform

$260

Aug-14-20

Resumed

Piper Sandler

Overweight

$250

Apr-20-20

Downgrade

Needham

Buy → Hold

Mar-02-20

Upgrade

Raymond James

Mkt Perform → Outperform

$183

May-07-19

Reiterated

Needham

Buy

$155 → $158

Apr-16-19

Downgrade

BTIG Research

Buy → Neutral

Mar-13-19

Reiterated

Needham

Buy

$148 → $155

Dec-19-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-14-18

Initiated

Needham

Buy

$139

Mar-09-18

Initiated

Barclays

Overweight

$97

Aug-14-17

Upgrade

BTIG Research

Neutral → Buy

$100

Apr-04-17

Reiterated

Wedbush

Outperform

$95 → $100

Mar-16-17

Downgrade

Piper Jaffray

Overweight → Neutral

Feb-27-17

Reiterated

Wedbush

Outperform

$85 → $95

Feb-13-17

Downgrade

Raymond James

Outperform → Mkt Perform

Aug-04-16

Reiterated

Wedbush

Outperform

$60 → $63

May-05-16

Upgrade

Piper Jaffray

Neutral → Overweight

May-05-16

Reiterated

Wedbush

Outperform

$51 → $57

Jan-06-16

Downgrade

Raymond James

Strong Buy → Outperform

Aug-05-15

Reiterated

ROTH Capital

Buy

$39 → $46

May-03-21 02:00AM	Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy Business Wire
Apr-27-21 11:35AM	Masimo (MASI) Earnings and Revenues Beat Estimates in Q1 Zacks -5.50%
Apr-26-21 11:30PM	Masimo (MASI) Q1 2021 Earnings Call Transcript Motley Fool
05:35PM	Masimo (MASI) Q1 Earnings and Revenues Top Estimates Zacks
04:05PM	Masimo Reports First Quarter 2021 Financial Results Business Wire
06:30AM	Introducing Masimo (NASDAQ:MASI), The Stock That Soared 468% In The Last Five Years Simply Wall St.
Apr-21-21 12:50PM	Heres Why Masimo (MASI) Landed in Ensemble Capitals Detractor List Insider Monkey
Apr-19-21 04:16PM	Masimo Reschedules Date of First Quarter 2021 Financial Results Conference Call Business Wire
03:50PM	Is MASI Stock A Buy or Sell? Insider Monkey
Apr-14-21 04:00PM	Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27 Business Wire
01:30PM	Here's Why You Should Hold Masimo (MASI) in Your Portfolio Zacks
Apr-12-21 08:00AM	Masimo Announces FDA Clearance of Radius PCG for the Root® Patient Monitoring and Connectivity Platform Business Wire
Apr-06-21 09:00AM	Masimo to Present in 20th Annual Needham Healthcare Conference Business Wire
02:00AM	Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3® Business Wire
Apr-02-21 05:55AM	Masimo (MASI) Benefitted From the Demand for Health Care, Polen Capital Says Insider Monkey
Mar-29-21 09:15AM	Ecolab (ECL) Unveils Its Enhanced Smart Water Navigator Zacks
02:00AM	Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G with RRp® Business Wire
Mar-25-21 11:30AM	Masimo (MASI) Down 10.2% Since Last Earnings Report: Can It Rebound? Zacks
Mar-23-21 01:26PM	New Study Favors Masimo's (MASI) Pulse Oximetry to Screen CCHD Zacks
Mar-22-21 03:00AM	Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry Business Wire
Mar-19-21 05:11AM	With EPS Growth And More, Masimo (NASDAQ:MASI) Is Interesting Simply Wall St.
Mar-18-21 08:38AM	Masimo's (MASI) EMMA Favored by New Study for Children Zacks
Mar-15-21 03:00AM	New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy Business Wire
Mar-08-21 05:51AM	The Zacks Analyst Blog Highlights: Abbott, Johnson & Johnson, Masimo Corp and Medtronic Zacks
12:00AM	Masimo Monitoring Solutions Promote Newborn and Maternal Safety Business Wire
Mar-05-21 08:56AM	4 Stocks to Watch as FDA Action Plan Stresses MedTech Digitization Zacks
Mar-04-21 09:17AM	Masimo's (MASI) Rad-G with Temperature Receives CE Marking Zacks
Mar-02-21 02:00AM	Masimo Announces CE Marking of the Rad-G with Temperature Business Wire
Feb-24-21 09:00AM	Masimo to Present in Raymond James 42nd Annual Institutional Investors Conference Business Wire
02:02AM	Masimo (MASI) Q4 2020 Earnings Call Transcript Motley Fool
Feb-23-21 04:34PM	Recap: Masimo Q4 Earnings Benzinga
04:05PM	Masimo Reports Fourth Quarter and Full-Year 2020 Financial Results Business Wire
08:00AM	Masimo Announces U.S. Release of softFlow® High-Flow Nasal Cannula Therapy Business Wire
Feb-22-21 10:04AM	Earnings Outlook For Masimo Benzinga
Feb-16-21 09:00AM	Masimo to Report Fourth Quarter and Full Year 2020 Financial Results after Market Close on Tuesday, February 23 Business Wire
Feb-15-21 08:00AM	Masimo Announces Full Market Release of Masimo SafetyNet-OPEN Business Wire
Feb-11-21 09:55AM	Medtronic's (MDT) Nellcor Favored in Study Over Masimo's Oximetry Zacks
Feb-10-21 09:00AM	Masimo to Present in BTIG MedTech and Digital Health Conference Business Wire
Feb-05-21 12:10PM	Why the Earnings Surprise Streak Could Continue for Masimo (MASI) Zacks
Feb-02-21 08:00AM	Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc Business Wire
Jan-20-21 09:01AM	Masimo's (MASI) iSirona to Boost Hospital Automation Platform Zacks
Jan-19-21 08:00AM	Masimo Announces the iSirona Connectivity Hub Business Wire
Jan-15-21 10:25AM	Masimo (MASI) Reports Encouraging 2020 Preliminary Results Zacks
Jan-14-21 09:23AM	Digital Health M&As Gain Precedence in the New Normal Zacks -5.25%
Jan-13-21 04:11PM	Masimo Announces Select Preliminary Full-Year 2020 Financial Results and 2021 Guidance Business Wire
Jan-12-21 11:07AM	Top Stocks for 2021 Motley Fool
03:11AM	Are Robust Financials Driving The Recent Rally In Masimo Corporation's (NASDAQ:MASI) Stock? Simply Wall St.
Dec-24-20 08:58AM	Masimo's (MASI) Telehealth Solution Helps in COVID-19 Crisis Zacks
Dec-21-20 08:00AM	Masimo Helps Clinicians at Renown Health Manage the COVID-19 Surge Business Wire
Dec-14-20 12:46PM	Masimo (MASI) Releases Favorable Findings on Pulse Oximetry Zacks
02:00AM	Researchers Use Masimo ORi, Oxygen Reserve Index, to Help Suppress Postoperative Hyperoxia in Patients Undergoing Breast Surgery Business Wire
Dec-10-20 02:00AM	New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion Business Wire
Dec-07-20 09:20AM	Masimos COVID-19 Response Efforts Highlighted at California Life Sciences Associations Pantheon 2020 Business Wire
02:02AM	The Trends At Masimo (NASDAQ:MASI) That You Should Know About Simply Wall St.
Nov-30-20 09:00AM	Masimo to Present in Piper Sandler Virtual Healthcare Conference Business Wire
02:00AM	Study Comparing Two Noninvasive Indicators of Fluid Responsiveness on Mechanically Ventilated Patients Finds Masimo PVi® Effective and Advantageous Business Wire
Nov-16-20 09:00AM	Masimo to Present in Stifel Virtual Healthcare Conference Business Wire
02:00AM	Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients Business Wire
Nov-14-20 08:00AM	Abbott Labs, Intuitive Surgical Headline 5 Top Stocks Near Buy Points Investor's Business Daily
Nov-09-20 05:41PM	Top Donors to Biden 2020 Campaign Investopedia
Nov-05-20 10:24AM	Did You Miss Masimo's (NASDAQ:MASI) Whopping 478% Share Price Gain? Simply Wall St.
Nov-04-20 04:39PM	Stock Upgrades: Dexcom Shows Rising Relative Strength Investor's Business Daily
Nov-02-20 02:00AM	Masimo Announces Limited Market Release of Radius VSM Business Wire
Oct-28-20 09:26AM	Masimo (MASI) Earnings and Revenues Beat Estimates in Q3 Zacks -7.00%
03:01AM	Masimo (MASI) Q3 2020 Earnings Call Transcript Motley Fool
Oct-27-20 05:45PM	Masimo (MASI) Q3 Earnings and Revenues Top Estimates Zacks
04:21PM	Masimo: Q3 Earnings Insights Benzinga
04:05PM	Masimo Reports Third Quarter 2020 Financial Results Business Wire
Oct-25-20 02:42PM	The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs Benzinga
Oct-22-20 02:24PM	Idexx Laboratories Stock Forming Handle Ahead Of Earnings Report Investor's Business Daily
Oct-20-20 01:43PM	Masimo Near Later-Stage Buy Point Ahead Of Earnings Report Investor's Business Daily
12:31PM	Masimo (MASI) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
09:00AM	Masimo to Report Third Quarter 2020 Financial Results after Market Close on Tuesday, October 27 Business Wire
Oct-19-20 08:00AM	Dr. Augusto Sola, Masimo VP of Medical Affairs for Neonatology, Honored by the American Academy of Pediatrics with Pioneer Award Business Wire
Oct-13-20 12:10PM	Why Masimo (MASI) is Poised to Beat Earnings Estimates Again Zacks
03:00AM	Highly Rated Masimo Forms Later-Stage Base With Earnings Due Investor's Business Daily
Oct-12-20 02:00AM	Researchers Use Masimo ORi, Oxygen Reserve Index, to Predict the Need for Postoperative Oxygen Therapy in Pediatric Patients with Obstructive Sleep Apnea Business Wire
Oct-08-20 10:17AM	Masimo Unveils New Wearable Wireless Continuous Thermometer Zacks
Oct-07-20 04:18PM	Masimo Gives Its First 2020 Guidance After Covid-19 'Uncertainties'; MASI Stock Rises Investor's Business Daily
07:30AM	The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences Benzinga
Oct-06-20 05:00PM	Masimo Announces Select Preliminary Third Quarter 2020 Financial Results and Updated Full-Year 2020 Guidance Business Wire
Oct-05-20 08:00AM	Masimo Announces Consumer Launch of the Radius Tº Continuous Thermometer, a More Convenient Way to Keep Track of Fever Business Wire
Oct-02-20 09:40AM	Masimo's (MASI) Rad-G Pulse Oximeter Receives FDA Clearance Zacks
Sep-30-20 10:38AM	What Can We Conclude About Masimo's (NASDAQ:MASI) CEO Pay? Simply Wall St.
Sep-29-20 01:20PM	Apple Accused of Delaying Masimo Legal Fight to Gain Watch Sales Bloomberg
Sep-28-20 08:00AM	Masimo Announces FDA Clearance of the Rad-G Pulse Oximeter Business Wire
Sep-14-20 11:36PM	Masimo Corporation (MASI): Hedge Funds Are Nibbling Insider Monkey
09:00AM	Masimo to Present in Morgan Stanley 18th Annual Global Healthcare Conference Business Wire
Sep-10-20 08:00AM	12 Stocks Easily Beat The Market For Five Years ... And Counting Investor's Business Daily
Sep-02-20 12:47PM	Modern Healthcare Honors Dr. Peter Pronovost as a Top 25 Innovator for Spearheading Remote Monitoring Program at University Hospitals Using Masimos Technology Business Wire
10:20AM	Benzinga's Top Upgrades, Downgrades For September 2, 2020 Benzinga
Sep-01-20 08:11AM	Masimo's (MASI) O3 Regional Oximetry Attains FDA Approval Zacks
Aug-31-20 02:09PM	Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued? Simply Wall St.
09:18AM	Masimo O3® Regional Oximetry Receives FDA Clearance for Somatic Applications and Measurement of Relative Changes in Cerebral Hemoglobin Business Wire
Aug-27-20 11:31AM	Masimo (MASI) Down 0.3% Since Last Earnings Report: Can It Rebound? Zacks
Aug-21-20 12:33PM	Masimo Releases Favorable Study Results on Pulse Oximetry Zacks
Aug-20-20 11:11AM	Why Masimo Corp (MASI) Stock is a Compelling Investment Case Insider Monkey
Aug-19-20 02:00AM	New Studies Investigate the Accuracy of Noninvasive, Continuous Hemoglobin Monitoring with Masimo SpHb® on Neonates Business Wire
Aug-17-20 08:02AM	Masimo PVi Gets FDA Approval to Measure Fluid Responsiveness Zacks
Aug-16-20 02:31PM	Masimo Gets FDA Clearance For Tracking Tool In Ventilated Adult Patients SmarterAnalyst

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McClenahan Thomas Samuel	EVP, GEN COUNSEL & CORP SEC	May 03	Buy	230.00	500	115,000	23,071	May 04 04:13 PM
McClenahan Thomas Samuel	EVP, GEN COUNSEL & CORP SEC	Apr 30	Buy	233.24	500	116,620	22,571	May 04 04:13 PM
Young Micah W	EVP & Chief Financial Officer	Apr 08	Option Exercise	86.95	2,087	181,465	16,680	Apr 12 04:08 PM
Young Micah W	EVP & Chief Financial Officer	Apr 08	Sale	239.00	2,087	498,793	14,593	Apr 12 04:08 PM
KIANI JOE E	CEO and Chairman of the Board	Jan 12	Sale	280.32	3,403	953,943	80,404	Jan 14 04:03 PM
REYNOLDS CRAIG B	Director	Jan 11	Option Exercise	23.04	10,000	230,400	14,300	Jan 13 04:06 PM
REYNOLDS CRAIG B	Director	Jan 11	Sale	279.74	10,000	2,797,412	4,300	Jan 13 04:06 PM
KIANI JOE E	CEO and Chairman of the Board	Jan 11	Sale	280.45	9,034	2,533,563	83,807	Jan 11 06:16 PM
KIANI JOE E	CEO and Chairman of the Board	Jan 08	Sale	281.93	52,698	14,856,989	92,841	Jan 11 06:16 PM
KIANI JOE E	CEO and Chairman of the Board	Jan 07	Sale	280.05	1,542	431,833	145,539	Jan 11 06:16 PM
Lee Yongsam	EVP, CIO	Jan 02	Option Exercise	0.00	2,000	0	77,000	Jan 06 04:16 PM
Coleman Jon	Pres-WW OEM & Global Health	Jan 02	Option Exercise	0.00	2,000	0	14,465	Jan 06 04:14 PM
KIANI JOE E	CEO and Chairman of the Board	Jan 02	Option Exercise	0.00	20,000	0	179,241	Jan 06 04:12 PM
McClenahan Thomas Samuel	EVP, GEN COUNSEL & CORP SEC	Jan 02	Option Exercise	0.00	2,000	0	8,264	Jan 06 04:10 PM
Sampath Anand	EVP, Ops & Clinical Research	Jan 02	Option Exercise	0.00	2,000	0	15,782	Jan 06 04:08 PM
Coleman Jon	Pres-WW OEM & Global Health	Dec 28	Option Exercise	31.01	8,250	255,832	20,715	Dec 30 04:21 PM
Coleman Jon	Pres-WW OEM & Global Health	Dec 28	Sale	264.02	8,250	2,178,165	12,465	Dec 30 04:21 PM
Sampath Anand	EVP, Ops & Clinical Research	Dec 15	Option Exercise	26.39	30,000	791,700	28,782	Dec 17 05:23 PM
Sampath Anand	EVP, Ops & Clinical Research	Dec 15	Sale	265.59	30,000	7,967,805	13,782	Dec 17 05:23 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 11	Option Exercise	28.03	6,038	169,245	165,279	Dec 14 04:04 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 11	Sale	271.31	6,038	1,638,153	159,241	Dec 14 04:04 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 10	Option Exercise	28.03	36,626	1,026,627	195,867	Dec 14 04:04 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 10	Sale	270.50	36,626	9,907,333	159,241	Dec 14 04:04 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 09	Option Exercise	28.03	1,365	38,261	160,606	Dec 10 05:15 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 09	Sale	270.33	1,365	369,001	159,241	Dec 10 05:15 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 08	Option Exercise	28.03	55,971	1,568,867	215,212	Dec 10 05:15 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 08	Sale	270.68	55,971	15,150,269	159,241	Dec 10 05:15 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 04	Option Exercise	28.03	11,688	327,615	170,929	Dec 07 04:09 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 04	Sale	261.50	11,688	3,056,413	159,241	Dec 07 04:09 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 03	Option Exercise	28.03	88,312	2,475,385	247,553	Dec 07 04:09 PM
KIANI JOE E	CEO and Chairman of the Board	Dec 03	Sale	263.13	88,312	23,237,590	159,241	Dec 07 04:09 PM
KIANI JOE E	CEO and Chairman of the Board	Oct 27	Option Exercise	28.03	47,508	1,331,649	206,749	Oct 29 04:06 PM
REYNOLDS CRAIG B	Director	Oct 27	Option Exercise	23.04	10,000	230,400	14,300	Oct 29 04:09 PM
KIANI JOE E	CEO and Chairman of the Board	Oct 27	Sale	250.47	47,508	11,899,167	159,241	Oct 29 04:06 PM
REYNOLDS CRAIG B	Director	Oct 27	Sale	250.00	10,000	2,500,000	4,300	Oct 29 04:09 PM
Young Micah W	EVP & Chief Financial Officer	Oct 19	Option Exercise	84.97	10,000	849,700	10,000	Oct 21 05:09 PM
Young Micah W	EVP & Chief Financial Officer	Oct 19	Sale	239.00	10,000	2,390,000	0	Oct 21 05:09 PM
REYNOLDS CRAIG B	Director	Oct 12	Option Exercise	23.04	20,000	460,800	14,300	Oct 14 04:14 PM
REYNOLDS CRAIG B	Director	Oct 12	Sale	240.10	20,000	4,802,100	4,300	Oct 14 04:14 PM
Muhsin Bilal	Chief Operating Officer	Oct 07	Option Exercise	34.51	25,000	862,750	25,000	Oct 09 04:08 PM
KIANI JOE E	CEO and Chairman of the Board	Oct 07	Option Exercise	28.03	52,492	1,471,351	211,733	Oct 09 04:17 PM
Lee Yongsam	EVP, CIO	Oct 07	Option Exercise	37.84	10,000	378,400	85,000	Oct 09 04:10 PM
McClenahan Thomas Samuel	EVP, GEN COUNSEL & CORP SEC	Oct 07	Option Exercise	29.52	10,000	295,200	11,264	Oct 09 04:13 PM
Lee Yongsam	EVP, CIO	Oct 07	Sale	250.00	10,000	2,500,000	75,000	Oct 09 04:10 PM
Muhsin Bilal	Chief Operating Officer	Oct 07	Sale	251.00	25,000	6,275,000	0	Oct 09 04:08 PM
McClenahan Thomas Samuel	EVP, GEN COUNSEL & CORP SEC	Oct 07	Sale	254.00	10,000	2,540,000	6,264	Oct 09 04:13 PM
KIANI JOE E	CEO and Chairman of the Board	Oct 07	Sale	250.87	52,492	13,168,511	159,241	Oct 09 04:17 PM
Coleman Jon	Pres-WW Sales,Pro Svc,Med Affs	Jul 06	Option Exercise	31.01	1,250	38,762	13,715	Jul 08 04:05 PM
Coleman Jon	Pres-WW Sales,Pro Svc,Med Affs	Jul 06	Sale	235.00	1,250	293,750	12,465	Jul 08 04:05 PM
Mikkelson Adam	Director	Jun 08	Sale	216.01	1,498	323,583	2,802	Jun 08 05:31 PM
Cohen H Michael	Director	Jun 04	Sale	225.37	587	132,292	717	Jun 08 05:05 PM
REYNOLDS CRAIG B	Director	May 29	Option Exercise	240.19	1,304	313,208	4,300	Jun 02 05:40 PM
Cohen H Michael	Director	May 29	Option Exercise	240.19	1,304	313,208	1,304	Jun 02 05:36 PM
Shimer Julie Ann	Director	May 29	Option Exercise	240.19	1,304	313,208	1,304	Jun 02 05:33 PM
Mikkelson Adam	Director	May 29	Option Exercise	240.19	1,304	313,208	4,300	Jun 02 05:27 PM
Harkin Thomas	Director	May 29	Option Exercise	240.19	1,304	313,208	7,685	Jun 02 05:25 PM
Barker Steven	Director	May 29	Option Exercise	240.19	1,304	313,208	67,549	Jun 02 05:23 PM
FITCH SANFORD	Director	May 29	Option Exercise	240.19	1,304	313,208	54,522	Jun 02 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience